| Host: |
Expi293 cells |
| Reactivity: |
SARS-COV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-COV-2 Spike S1-C-His-Avi protein was developed from expi293 cells and has a target region of C-His-Avi. For use in research applications. |
| Conjugation: |
Biotin |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: |
Immobilized Biotinylated SARS-COV-2 Spike S1, His Tag at 0.5 Mu g/ml (100 Mu l/Well). Dose response curve for Human ACE2, hFc Tag with the EC50 of 16.1ng/ml determined by ELISA. |
| Immunogen Region: |
Gln14-Arg683 |
| Immunogen: |
Biotinylated Recombinant SARS-COV-2 SARS-COV-2 Spike S1 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-COV-2 SARS-COV-2 Spike S1 fused with His tag and Avi tag at the C-terminal. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
